Studies related to Blood Pressure and Berberine

Effect Of Berberine Administration On Metabolic Syndrome, Insulin Sensitivity, And Insulin Secretion

Effect Decrease
Values Decrease in systolic only after 3 months: 123mmHg in placebo versus 115±9 mmHg with berberine.
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 24
Sex Both Genders
Body Types Obese, Overweight
Notes for this study:
24 people with metabolic syndrome were randomized to placebo or 0.5g berberine three times a day for three months. Decrease in waist circumference in females only, systolic blood pressure, triglycerides, area under the curve of glucose and insulin, and Matsuda index were all seen to be significant in the berberine group versus placebo.